Artificial intelligence to spot early diabetic eye damage in people with prediabetes or diabetes
Examines adults with prediabetes or diabetes for early signs of diabetic retinopathy.
Plain-language title generated from the registry record
Registry title: Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI)
Key facts
- Where
- Tübingen, GermanySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07378891, who can take part
Where in Germany
- University Hospital Tuebingen, Dep. DiabetologyTübingen, GermanyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Tuebingen
- Trial code
- NCT07378891
- Record updated
- 10 February 2026
- Original description
Examination of individuals with prediabetes and established diabetes for early signs of diabetic retinopathy.Read full original descriptionShow less
Künstliche Intelligenz (KI)-gestützte Früherkennung Der Diabetischen Retinopathie (FUNDUS-KI)
Examination of individuals with prediabetes and established diabetes for early signs of diabetic retinopathy.
Inclusion: Voluntary adults; Aged between 18 and 80 years; Understanding of the study explanations and instructions; Prediabetes (defined by elevated fasting glucose 100-125 mg/dL and/or 2-hour glucose in the oral glucose tolerance test of 140-199 mg/dL and/or HbA1c of 5.7-6.4%); manifest diabetes (all types of diabetes according to Ahlqvist).
Exclusion: Uncontrolled arterial hypertension (Stage III) despite multiple antihypertensive medications; Eye diseases that impair the interpretability of the fundus examination; participants unable to give consent; Those who do not agree to be informed about incidentally detected pathological findings.